Ongentys (opicapone) - Ono Pharma, Neurocrine, BIAL
https://www.mdsabstracts.org/abstract/long-term-effect-of-opicapone-in-parkinsons-patients-without-motor-complications-1-5-year-epsilon-study-findings/
 
J. Ferreira; O. Rascol; F. Stocchi; A. Antonini; H. Brigas; J. Moreira; JF. Rocha; M. Fonseca; J. Holenz; W. Poewe
 
Oct 16, 2025
 
Prev Next